Trax Surgical performed its first case using its REDIFIX implant as part of a mid-foot reconstruction.
Trax Surgical received its FDA 510(k) clearance to market the REDIFIX Suture Anchor in late April of this year. The system features a cannulated, threaded distal implant connected to a proximal implant by a loop of high‑strength suture and a sliding knot. Delivery is straightforward: a guidewire is placed, a pilot hole is drilled, and the implant is advanced into position over the wire. The proximal implant and target tissues are then reduced by applying traction to the trailing suture.
Shane Shankle, CEO of Trax Surgical said, “In a short time, we’ve built a catalog of widely used extremity products. The REDIFIX system offers meaningful advantages, and we believe it will become a standard tool in orthopedics.”
Trax Surgical performed its first case using its REDIFIX implant as part of a mid-foot reconstruction.
Trax Surgical received its FDA 510(k) clearance to market the REDIFIX Suture Anchor in late April of this year. The system features a cannulated, threaded distal implant connected to a proximal implant by a loop of high‑strength suture and a...
Trax Surgical performed its first case using its REDIFIX implant as part of a mid-foot reconstruction.
Trax Surgical received its FDA 510(k) clearance to market the REDIFIX Suture Anchor in late April of this year. The system features a cannulated, threaded distal implant connected to a proximal implant by a loop of high‑strength suture and a sliding knot. Delivery is straightforward: a guidewire is placed, a pilot hole is drilled, and the implant is advanced into position over the wire. The proximal implant and target tissues are then reduced by applying traction to the trailing suture.
Shane Shankle, CEO of Trax Surgical said, “In a short time, we’ve built a catalog of widely used extremity products. The REDIFIX system offers meaningful advantages, and we believe it will become a standard tool in orthopedics.”
Copy to clipboard 
